Product Information
APTENSIO XR 20 MG CAPSULE is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $7.9968 per EA under NDC 42858040345. Its NADAC has been published 187 times since Jan 17, 2018.
Strength
20 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858040345
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/18/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205831On Market Since
4/17/2015
Pharmacological Classes
Price Statistics
The NADAC for APTENSIO XR 20 MG CAPSULE has been published 187 times since Jan 17, 2018, and over the history we have for it it has risen 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9968 per EA |
|---|---|
| All-time high | $7.9968 (Jun 10, 2026) |
| All-time low | $6.8607 (Jan 17, 2018) |
| 52-week high | $7.9968 |
| 52-week low | $7.9968 |
| Median price | $7.9706 |
| Average price | $7.7391 |
| Largest weekly change | +10.0% (Jun 6, 2018) |
| Weeks tracked | 187 |
| Tracking since | Jan 17, 2018 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of APTENSIO XR 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APTENSIO XR 20 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $7.9968 per EA (NDC 42858040345), effective Jun 10, 2026.
How has the price of APTENSIO XR 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APTENSIO XR 20 MG CAPSULE has risen 16.6%. It has been tracked across 187 weekly CMS publications since Jan 17, 2018.
What are the highest and lowest recorded NADAC prices for APTENSIO XR 20 MG CAPSULE?
Since Jan 17, 2018, the NADAC for APTENSIO XR 20 MG CAPSULE has ranged from a low of $6.8607 (Jan 17, 2018) to a high of $7.9968 (Jun 10, 2026), with a median of $7.9706 per EA.
Are there cheaper alternatives to APTENSIO XR 20 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE CD 20 MG CAP, is $1.4523 per EA — about 82% below APTENSIO XR 20 MG CAPSULE.
Who manufactures APTENSIO XR 20 MG CAPSULE?
APTENSIO XR 20 MG CAPSULE (NDC 42858040345) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.
Related Drugs
Same classification